Skip to main
WALD

WALD Stock Forecast & Price Target

WALD Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 67%
Buy 0%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Waldencast is currently undergoing a strategic review in order to maximize shareholder value and bridge the perceived disconnect between its market value and brand assets. The company has recently sold off its Obagi Japan trademark rights and is focusing on developing and marketing new products, particularly in the Milk Makeup segment. However, risks such as reliance on third-party suppliers, potential dilution from new securities, and an ongoing SEC investigation could impact the company's future performance, along with a slowing beauty market and inflation in supply chain costs. Despite these risks, the company has a strong leadership team and is proactively addressing its challenges, indicating positive potential for future growth.

Bears say

Waldencast is facing several challenges in both its Obagi Skincare and Milk Makeup segments. Both segments experienced a decline in gross margin, with Obagi recording a significant 580bps decrease. This, in combination with lower-than-expected revenue and earnings results, suggests potential issues with the brand's pricing power and ability to drive demand. Adding to concerns is the fact that the company is still undergoing a strategic review and has not provided any guidance for the next fiscal year, leaving uncertainty regarding future performance.

WALD has been analyzed by 3 analysts, with a consensus rating of Buy. 67% of analysts recommend a Strong Buy, 0% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waldencast Acquisition Corp and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waldencast Acquisition Corp (WALD) Forecast

Analysts have given WALD a Buy based on their latest research and market trends.

According to 3 analysts, WALD has a Buy consensus rating as of May 5, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $2, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $2, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waldencast Acquisition Corp (WALD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.